Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2008

View Archived Issues

Antisense oligonucleotide microsphere vaccine prevents type 1 diabetes in vivo

Novel antiarthritic compounds reported in recent patents

Avapro to soon be launched in Japan for the treatment of hypertension

Emisphere and Novo Nordisk to collaborate on development of oral GLP-1 receptor agonists

Ovation to in-license ATryn in the U.S.

Akesis to initiate 13-week animal study for AKP- 020

AVE-1642 well tolerated in advanced solid tumor patients

BioGeneriX and Neose initiate phase II GlycoPEG-GCSF trial

Mechanism-based target modulation evidenced with SNS-032 treatment

FDA approves PrandiMet, a repaglinide and metformin fixed-dose tablet

Tanezumab appears safe and effective in phase II study in patients with osteoarthritic pain

Genmab initiates phase I/II zalutumumab with radiotherapy for advanced head and neck cancer

Vaccination with ChimeriVax-Dengue safe and immunogenic in phase II study

Albiglutide safe and well tolerated in early clinical studies

Elacyt gets orphan drug designation in U.S.

CuraGen commences phase II CR011-vcMMAE trial in advanced breast cancer

Recent Santen patents describe novel agents for metabolic disorders

Abbott patents DGAT-1 inhibitors

FDA approves Kinrix combination vaccine for children

Morria initiates phase II multi-dose MRX-4 study in allergic rhinitis

New Aptivus solution approved for treatment-experienced pediatric HIV patients

UCB reports results preliminary results from phase IIa lacosamide trial

Nymox presents new data for NX-1207 in benign prostatic hyperplasia

European Commission approves Roche's shortened Pegasys regimen for HCV

FDA Advisory Committee recommends approval of tolvaptan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...